Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Reprise Biomedical, Inc.
483
•Reprise Biomedical, Inc.•November 20, 2025

Reprise Biomedical, Inc. – FDA 483, Nov 20, 2025

Record Details

An FDA inspection was conducted at Reprise Biomedical, Inc. from November 19-20, 2025, resulting in the issuance of an FDA Form 483. The main violation observed was an inadequate risk analysis for the company's Miro3D wound matrix product. Specifically, the firm's risk documents, including the Miro3D Design FMEA and Miro3D UFMEA, did not adequately consider the potential harm of death as a consequence of patient infection due to the use of a nonsterile product. The maximum severity level assigned for patient infection was listed as "Serious," requiring medical or surgical intervention, which does not encompass the full range of severe outcomes. This observation indicates a deficiency in the firm's quality system and risk management practices, falling under the regulatory purview of the Federal Food, Drug, and Cosmetic Act. Reprise Biomedical, Inc. is required to respond to this observation by either discussing any objections with the FDA or by implementing corrective actions to ensure their risk assessments are comprehensive and account for all potential severe harms.

Company
Reprise Biomedical, Inc.
Inspection date
November 20, 2025
Product type
devices
Office
Minneapolis District Office
Person
  • Tyler R. Courtney (investigator)
View Company Profile

ID · dd30f6d6-5ce4-4a26-affd-1e0479df319a

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Reprise Biomedical, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.